Beijing Boren Hospital clinical trial pipeline

10 trials changed in the last 30 days: 7 stopped, 3 with notable changes, 0 with minor changes only.

1. Stopped

   Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory…Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

   Trial status changed: Recruiting → Withdrawn

   Beijing Boren Hospital·Phase 1· NCT07361094· Registry history of NCT07361094 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

2. Stopped

   AFN50 · Autoimmune Diseases

   Trial status changed: Recruiting → Withdrawn

   Also in this update: Primary completion date changed from estimate of Feb 29, 2028 to Apr 30, 2026

   Beijing Boren Hospital·Early Phase 1· NCT07448298· Registry history of NCT07448298 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

3. Stopped

   CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

   Trial status changed: Recruiting → Withdrawn

   Also in this update: Primary completion date changed from estimate of Feb 20, 2027 to Apr 30, 2026

   Beijing Boren Hospital·Not applicable· NCT06983964· Registry history of NCT06983964 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

4. Stopped

   CAR-T Cells Targeting Autoimmune Diseases

   Withdrawn before enrolling

   Also in this update: Primary completion date changed from estimate of Apr 20, 2028 to Apr 30, 2026

   Beijing Boren Hospital·Not applicable· NCT06661811· Registry history of NCT06661811 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

5. Stopped

   Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune…Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

   Trial status changed: Recruiting → Withdrawn

   Beijing Boren Hospital·Not applicable· NCT06993493· Registry history of NCT06993493 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

6. Stopped

   Autologous BCMA-targeted CAR-T Cell Injection for…Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

   Trial status changed: Recruiting → Withdrawn

   Beijing Boren Hospital·Early Phase 1· NCT07626476· Registry history of NCT07626476 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

7. Stopped

   Targeted BCMA Autologous CART Cell Injection…Targeted BCMA Autologous CART Cell Injection · Recurrent/Refractory Light Chain Amyloidosis

   Trial status changed: Recruiting → Withdrawn

   Beijing Boren Hospital·Not applicable· NCT06983951· Registry history of NCT06983951 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

8. Notable

   BEN301 Injection · Autoimmune Diseases

   Enrollment reduced: 24 → 2 participants

   Also in this update: Recruitment opened; Primary and study completion moved earlier from Feb 28, 2029 to Apr 30, 2027

   Beijing Boren Hospital·Early Phase 1· NCT07502859· Registry history of NCT07502859 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

9. Notable

   FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune…FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients

   Trial status changed: Suspended → Withdrawn

   Beijing Boren Hospital·Early Phase 1· NCT07604792· Registry history of NCT07604792 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

10. Notable

    Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for…Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

    Trial status changed: Suspended → Withdrawn

    Beijing Boren Hospital·Phase 1· NCT07555561· Registry history of NCT07555561 on ClinicalTrials.gov (opens the registry)

    Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.